Pang et al. [103] identified activators of signal transducer and activator of transcription 3 (STAT3), mitogen-activated protein kinase 1 (MAPK1), and phosphoinositin-3 kinase regulatory subunit 1 (PIK3R1) as pharmacological targets of FA in the treatment of osteosarcoma through molecular docking analysis. The gene discussed is MAPK1; the disease is osteosarcoma.